HCW Biologics Inc. Investing Cash Flow
HCW Biologics Inc. (HCWB) reported Investing Cash Flow of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-31
- HCW Biologics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- HCW Biologics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- HCW Biologics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- HCW Biologics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- HCW Biologics Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- HCW Biologics Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$261.62K, a 106.89% decline from fiscal 2023.
- HCW Biologics Inc. net cash provided by (used in) investing activities for fiscal 2023 was $3.80M, a 74.18% decline from fiscal 2022.
- HCW Biologics Inc. net cash provided by (used in) investing activities for fiscal 2022 was $14.71M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | -$113.41K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $0.00 10-Q · filed 2025-08-18 | -$113.41K derived: sum of 3 quarters · filed 2026-03-31 | -$150.47K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | -$113.41K derived: sum of 2 quarters · filed 2026-03-31 | -$150.47K derived: sum of 3 quarters · filed 2026-03-31 | -$131.91K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | -$113.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$150.47K derived: sum of 2 quarters · filed 2026-03-31 | -$131.91K derived: sum of 3 quarters · filed 2026-03-31 | -$261.62K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$37.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$18.50K derived: sum of 2 quarters · filed 2025-11-14 | -$148.21K 10-Q · filed 2025-11-14 | -$3.86M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $18.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$111.14K 10-Q · filed 2025-08-18 | -$3.83M derived: sum of 3 quarters · filed 2025-08-18 | $5.54M derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | -$129.71K 10-Q · filed 2025-05-15 | -$3.85M derived: sum of 2 quarters · filed 2025-05-15 | $5.52M derived: sum of 3 quarters · filed 2025-05-15 | $3.97M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $5.65M derived: sum of 2 quarters · filed 2025-03-28 | $4.10M derived: sum of 3 quarters · filed 2025-03-28 | $3.80M 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.81M derived: sum of 2 quarters · filed 2024-11-14 | $7.51M 10-Q · filed 2024-11-14 | $7.44M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.86M 10-Q · filed 2024-08-14 | -$1.93M derived: sum of 3 quarters · filed 2024-08-14 | $4.89M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$300.38K 10-Q · filed 2024-05-15 | -$369.07K derived: sum of 2 quarters · filed 2024-05-15 | $6.44M derived: sum of 3 quarters · filed 2024-05-15 | $6.43M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$68.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-15 | $6.75M derived: sum of 2 quarters · filed 2024-05-15 | $6.73M derived: sum of 3 quarters · filed 2024-05-15 | $14.71M 10-K/A · filed 2024-05-15 |
| 2022-09-30 | $6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.80M derived: sum of 2 quarters · filed 2023-11-14 | $14.78M 10-Q · filed 2023-11-14 | $14.75M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$12.91K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-08-11 | $7.96M 10-Q · filed 2023-08-11 | $7.94M derived: sum of 3 quarters · filed 2023-08-11 | -$27.03M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $7.98M 10-Q/A · filed 2023-08-10 | $7.95M derived: sum of 2 quarters · filed 2023-08-10 | -$27.02M derived: sum of 3 quarters · filed 2023-08-10 | -$27.02M derived: sum of 4 quarters · filed 2023-08-10 |
| 2021-12-31 | -$23.90K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$35.00M derived: sum of 2 quarters · filed 2023-03-28 | -$35.00M derived: sum of 3 quarters · filed 2023-03-28 | -$35.02M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$34.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$34.97M derived: sum of 2 quarters · filed 2022-11-07 | -$35.00M 10-Q · filed 2022-11-07 | -$35.03M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$23.28K 10-Q · filed 2022-08-12 | -$59.67K derived: sum of 3 quarters · filed 2022-08-12 | -$164.88K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$23.28K 10-Q · filed 2022-05-13 | -$59.67K derived: sum of 2 quarters · filed 2022-05-13 | -$164.88K derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$36.39K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$141.61K derived: sum of 2 quarters · filed 2022-03-29 | -$186.68K 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$105.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$150.29K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$45.08K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |